New frontiers for stroke prevention in atrial fibrillation. - Wikidata - awgldk - TriplyDB

New frontiers for stroke prevention in atrial fibrillation.

New frontiers for stroke prevention in atrial fibrillation.

http://www.wikidata.org/entity/Q37977275

about

Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.Clinical diseases with thrombotic risk and their pharmacologycal treatment: how they change the therapeutic attitude in dental treatments.Etiologies of intracerebral hematomas.Dabigatran and left atrial appendage thrombus.Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.Paroxysmal atrial fibrillation after ischemic stroke: how should we hunt for it?Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis.A prospective study on the use of warfarin in the United arab emirates.

P2860

Q35335927-AE255674-2613-445A-B470-8C6A52C8AE75 Q37370565-3166C224-95D5-4EF6-A27D-F2C76AFC51DC Q38007885-3B54F0F8-B274-417B-83B0-AC17320FA339 Q38014343-DE9C9653-2450-4061-B0FF-61E2E22CB20F Q38081149-97CD2A85-62CA-4BE1-A19E-8155D12B62E0 Q38097511-AFAD6E92-43BE-44FE-8FF7-14F8196BAE96 Q38390896-8E1E817C-3D1B-4047-8F36-0162C3A5F237 Q41908505-EC2F73F7-9063-46EC-B8A5-202AE25993F2

P2860

New frontiers for stroke prevention in atrial fibrillation.

http://www.wikidata.org/entity/Q37977275

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New frontiers for stroke prevention in atrial fibrillation.

@en

New frontiers for stroke prevention in atrial fibrillation.

@nl

type

label

New frontiers for stroke prevention in atrial fibrillation.

@en

New frontiers for stroke prevention in atrial fibrillation.

@nl

prefLabel

New frontiers for stroke prevention in atrial fibrillation.

@en

New frontiers for stroke prevention in atrial fibrillation.

@nl

P1433

Q37977275-086E6EAF-EFFB-4551-8EF0-3D4C4F53B223

P1476

Q37977275-B7060AC0-A269-4FBA-8203-74843CA82220

P2093

Q37977275-F17140B0-BCCA-4552-B858-1FD4BB4ADDEB

P2860

Q37977275-0C9155F9-D319-47D9-B223-1FAA4CDA9316

Q37977275-0CC9744A-DAB8-4F03-9B78-0B5D84726351

Q37977275-10D8FA36-4771-4B3F-A745-BB9A84589EE8

Q37977275-11A6B813-6D20-4484-A0B3-5F2E4E6C6075

Q37977275-25ABCCE8-6360-4233-8E8F-4A0831CE9E6B

Q37977275-2A62E871-F542-4183-BB71-C141FA2E0D1B

Q37977275-32EA844A-BF89-41B3-BD7F-84DF7C811959

Q37977275-3505C9D0-4577-412C-8040-F795746ED665

Q37977275-37ECFE9B-4E16-46B8-AC0F-5E81306109B5

Q37977275-3A0031E7-36F5-4E82-8540-3DDCF78AF8DB

P304

Q37977275-A0B022B4-93BF-4430-A098-47F0CCE81190

P31

Q37977275-B6984B4B-1B29-4AA5-B569-361500144273

P356

Q37977275-AE7089FD-2754-4D71-B62C-4C5145FDAED1

P433

Q37977275-04263C63-826E-438C-9AC3-6EA72498F749

P478

Q37977275-C53703AA-ACD7-4AD4-AF39-3808B92C15A0

P50

Q37977275-8E9F3965-9C20-4655-9FDD-2C4D6537F67B

Q37977275-DE11EAAE-23F5-4E07-AF13-5747479D4CEF

P577

Q37977275-FE6495E5-1C18-4CFF-BE92-6307ACEC4739

P698

Q37977275-11495DBB-F6AC-4FE0-AF60-929B13D962DD

P921

Q37977275-3416224C-0B1B-487F-AB31-7B20BCE61190

P356

P1433

Cerebrovascular Diseases

P1476

New frontiers for stroke prevention in atrial fibrillation

@en

P2093

Rod S Passman

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Dabigatran versus warfarin in patients with atrial fibrillation

Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

P304

199-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000334979

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22261539

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation